1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Wozniak, A.; Schneider, B.; Kalemkerian, G.; Daly, R.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles
    Meeting Abstract

    Riely, G.; Lovly, C.; Messina, C.; Bienert, S.; Alexander, K.; Pao, W.; Magee, K.; Baxi, S.; Doebele, R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A multicenter phase 1/2a trial of CLN-081 in NSCLC with EGFR exon 20 insertion mutations
    Meeting Abstract

    Piotrowska, Z.; Planchard, D.; Clancy, M.; Witter, D.; Zawel, L.; Yu, H.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Preliminary phase 1 results of U3-1402: A novel HER3-targeted antibody-drug conjugate-in EGFR TKI-resistant, EGFR-mutant NSCLC
    Meeting Abstract

    Yu, H.; Johnson, M.; Steuer, C.; Vigliotti, M.; Chen, S.; Kamai, Y.; Yu, C.; Janne, P.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Entrectinib in patients with ROS1-positive NSCLC or NTRK fusion-positive solid tumors with CNS metastases
    Meeting Abstract

    Paz-Ares, L.; Dziadziuszko, R.; Drilon, A.; John, T.; Krebs, M.; Demetri, G.; Shaw, A.; Siena, S.; Wolf, J.; Farago, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Novel germline mutations in DNA-damage repair and DNA replication identified in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Guo, R.; Duboff, M.; Kris, M.; Ladanyi, M.; Mandelker, D.; Zauderer, M.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy
    Meeting Abstract

    Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Peripheral T cell repertoire evolution in resectable NSCLC treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; Caushi, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T.; Chan, H. Y.; Guo, H.; Merghoub, T.; Chaft, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • STK11/LKB1 genomic alterations are associated with inferior clinical outcomes with chemo-immunotherapy in non-squamous NSCLC
    Meeting Abstract

    Skoulidis, F.; Arbour, K.; Hellmann, M.; Patil, P.; Marmarelis, M.; Owen, D.; Awad, M.; Murray, J.; Levy, B.; Hellyer, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Multifactorial model to predict response to PD-(L)1 blockade in patients with high PD-L1 metastatic non-small cell lung cancer
    Meeting Abstract

    Arbour, K.; Oprescu, M.; Hakim, J.; Rizvi, H.; Leiserson, M.; Ginsburg, M.; Plodkowski, A.; Sauter, J.; Preeshagul, I.; Gillett, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save